TTNS

DEVICE4 trials

Sponsors

University of Sao Paulo General Hospital, University Hospital, Ghent, University of Alcala, Taipei Veterans General Hospital, Taiwan

Conditions

Overactive Bladder SyndromeProstate CancerSide Effects

Phase 4

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Taipei Veterans General Hospital, TaiwanOveractive Bladder Syndrome

Start: 2021-11-10End: 2023-09-30Target: 180Updated: 2022-01-12

Unknown Phase

Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment

CompletedNCT03250650

University of Sao Paulo General HospitalOveractive Bladder Syndrome

Start: 2017-03-09End: 2018-06-30Updated: 2019-04-17

TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)

TerminatedNCT04256876

University Hospital, GhentOveractive Bladder Syndrome

Start: 2018-11-07End: 2020-07-01Updated: 2023-01-04

Educational Program Plus Physiotherapy After Prostatectomy

University of AlcalaProstate Cancer, Side Effects

Start: 2019-12-01End: 2022-12-31Target: 84Updated: 2020-02-25

Related Papers

Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.

2021-04-024 citations